ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma
Related Posts
Chandra MS, Gagliano-Jucá T, Shekhar S, Pencina KM, Travison TG, Garg R, McDonnell ME, Reid KF, Latham NK, Lam H, Meritus D, Yan Y, Isaza[...]
Parsons JB, Westgeest AC, Conlon BP, Harbarth S, Howden BP, Kim YS, King HA, Lambregts MMC, Miller LG, Patel R, Wang M, Fowler VG Jr.[...]
Clark DC, Baden R, Banerjee J, Bedrossian R, Chute H, Davar K, Deng D, Donnelly M, Fernandez D, Goodman R, Gordon H, Harris E, Hutcheon[...]